Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MediWound Ltd. Proxy Solicitation & Information Statement 2015

Dec 23, 2015

33721_ffr_2015-12-23_4101aaa6-c9cc-4ca9-b2b2-0c25963069a5.zip

Proxy Solicitation & Information Statement

Open in viewer

Opens in your device viewer

6-K 1 zk1517760.htm 6-K zk1517760.htm Licensed to: ZKG Document Created using EDGARizer 2020 5.5.2.0 Copyright 1995 - 2015 Summit Financial Printing. All rights reserved.

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

Pursuant to Rule 13a-16 or 15d-16 of the

Securities Exchange Act of 1934

For the month of December 2015

Commission File Number: 001-36349

MediWound Ltd.

(Translation of registrant’s name into English)

42 Hayarkon Street

Yavne, 8122745 Israel

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F x Form 40-F o

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): __

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): __

CONTENTS

Annexed hereto and incorporated herein by reference are copies of the following items being furnished by MediWound Ltd. (the “Company”):

  1. Notice of Extraordinary General Meeting of the Company’s Shareholders and Proxy Statement, dated December 23, 2015, to be mailed to the shareholders of the Company in connection with the Extraordinary General Meeting of the Company’s Shareholders, which is scheduled to be held on January 28, 2016 (the “Meeting”), annexed as Exhibit 99.1 hereto.

  2. Proxy Card to be mailed to holders of the ordinary shares of the Company for use in connection with the Meeting, annexed as Exhibit 99.2 hereto.

2

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

MEDIWOUND LTD. — By: /s/ Sharon Malka
Name: Sharon Malka
Title: Chief Financial and Operations Officer

3

EXHIBIT INDEX

The following exhibits are furnished as part of this Form 6-K:

Exhibit Description
99.1 Notice of Extraordinary General Meeting and Proxy Statement, dated December 23, 2015, in connection with the Annual General Meeting of Shareholders of the Company scheduled to be held on January 28, 2016.
99.2 Proxy Card to be mailed to holders of the ordinary shares of the Company for use in connection with the Company’s Extraordinary General Meeting of Shareholders scheduled to be held on January 28, 2016.

4